Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 4.505
-0.050 (-1.10%)
Oct 22, 2026, 4:08 PM HKT
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of 3.67 billion as of October 21, 2026. It is the 14,993rd most valuable company in the world and the 668th biggest in Hong Kong. Its market cap has decreased by 42.68% in one year.
Market Cap
3.67B
Enterprise Value
3.40B
Revenue
1.08B
Global Rank
Country Rank
#668 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 21.28B to 3.67B, a decrease of -82.74%. That is a compound annual growth rate of -24.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 3.67B | -39.12% |
| Dec 31, 2025 | 6.03B | 64.39% |
| Dec 31, 2024 | 3.67B | -20.44% |
| Dec 29, 2023 | 4.61B | -30.21% |
| Dec 30, 2022 | 6.61B | -43.35% |
| Dec 31, 2021 | 11.67B | -26.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LongBio Pharma (Suzhou) | 4.82B |
| CK Life Sciences Int'l., (Holdings) | 4.81B |
| Abbisko Cayman | 4.72B |
| Jacobio Pharmaceuticals Group | 3.95B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.65B |
| Hanx Biopharmaceuticals (Wuhan) | 3.54B |
| TransThera Sciences (Nanjing) | 3.53B |